GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alkem Laboratories ALKEM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

5,398.50

+1.92%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹147.12bn

FY2017FY2026

Net income

₹23.02bn

FY2017FY2026

Free cash flow

₹13.46bn

FY2017FY2026

Shareholders' equity

₹138.20bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹147.12bn₹128.05bn₹124.39bn₹114.40bn₹105.12bn₹87.28bn₹81.92bn₹72.66bn₹63.04bn₹56.16bn
Gross profit₹96.19bn₹79.47bn₹74.07bn₹64.58bn₹62.29bn₹51.42bn₹47.39bn₹41.87bn₹38.15bn₹32.89bn
Research and development—₹5.62bn₹5.25bn₹5.41bn₹5.69bn₹5.34bn₹4.73bn₹4.62bn₹3.65bn₹3.20bn
Operating income₹30.32bn₹26.14bn₹21.19bn₹13.34bn₹18.85bn₹18.91bn₹12.73bn₹10.04bn₹8.94bn₹9.11bn
Net income₹23.02bn₹21.65bn₹17.96bn₹9.84bn₹16.46bn₹15.85bn₹11.27bn₹7.61bn₹6.31bn₹8.92bn
Diluted earnings per share192.51180.46150.1982.31137.63132.5594.2763.6152.7774.63

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹208.73bn₹176.91bn₹155.75bn₹137.57bn₹140.69bn₹115.19bn₹99.46bn₹82.08bn₹76.66bn₹65.68bn
Cash and short-term investments₹40.65bn₹37.78bn₹42.70bn₹11.43bn₹13.13bn₹17.54bn₹4.60bn₹6.54bn₹9.23bn₹6.93bn
Total liabilities₹65.24bn₹52.57bn₹48.60bn₹43.22bn₹52.22bn₹39.61bn₹36.37bn₹26.36bn₹26.80bn₹19.85bn
Debt—₹13.81bn₹14.18bn₹13.97bn₹26.68bn₹17.92bn₹17.23bn₹9.44bn₹9.98bn₹6.59bn
Shareholders' equity₹138.20bn₹119.85bn₹103.12bn₹90.45bn₹86.38bn₹73.77bn₹61.61bn₹54.39bn₹48.64bn₹44.68bn
Shares outstanding120m120m120m120m120m120m120m120m120m120m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹19.63bn₹19.13bn₹19.48bn₹16.82bn₹11.11bn₹12.65bn₹5.85bn₹7.77bn₹2.76bn₹4.71bn
Capital spending−₹6.17bn−₹6.76bn−₹2.59bn−₹2.33bn−₹3.39bn−₹1.95bn−₹3.63bn−₹5.29bn−₹6.84bn−₹6.45bn
Free cash flow₹13.46bn₹12.37bn₹16.89bn₹14.50bn₹7.72bn₹10.70bn₹2.22bn₹2.48bn−₹4.08bn−₹1.74bn
Dividends paid−₹6.14bn−₹5.05bn−₹5.38bn−₹5.30bn−₹4.22bn−₹3.35bn−₹4.40bn−₹2.19bn−₹2.18bn−₹863.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹37.40bn₹36.03bn₹37.37bn₹40.01bn₹33.71bn₹31.44bn₹33.74bn₹34.15bn
Gross profit₹16.30bn₹23.55bn₹24.64bn₹26.00bn₹22.00bn₹11.36bn₹21.70bn₹22.10bn
Operating income₹6.66bn₹4.12bn₹8.23bn₹9.31bn₹8.01bn₹3.07bn₹7.67bn₹8.08bn
Net income₹5.20bn₹2.36bn₹6.36bn₹7.65bn₹6.64bn₹3.06bn₹6.26bn₹6.89bn
Diluted earnings per share43.4919.7853.0063.7655.3625.4952.3457.59
Cash from operations———₹8.37bn—₹19.13bn—₹9.42bn
Capital spending———−₹3.96bn—−₹6.76bn—−₹3.06bn
Free cash flow———₹4.40bn—₹12.37bn—₹6.35bn
Total assets—₹208.73bn—₹202.87bn—₹176.91bn—₹171.17bn
Cash and short-term investments₹40.61bn₹40.65bn₹51.52bn₹51.52bn₹41.05bn₹37.78bn₹22.89bn₹22.89bn
Debt—₹16.70bn—₹23.56bn—₹13.81bn—₹14.78bn
Shareholders' equity₹143.49bn₹138.20bn₹138.11bn₹133.46bn₹124.34bn₹119.85bn₹119.10bn₹114.93bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%11.0%11.7%
Operating income31.5%9.9%14.7%
Net income32.7%7.7%12.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.8%61.2%60.6%59.9%
Operating margin20.5%17.7%18.2%17.2%
Net margin16.2%14.1%14.8%14.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings26.930.337.563.221.827.331.031.537.029.5
Price to sales4.25.15.45.43.45.04.33.33.74.7

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 7 Aug 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year10.0051.0042.0045.0029.0035.0028.0030.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.